Nxera Pharma announces the appointment of Kiyoshi Kaneko as Chief Commercial Officer and the promotion of Mariko Nakafuji to Chief Legal Officer. Both executives bring extensive experience in their respective fields and will play key roles in Nxera's growth strategy in Japan.
Who to call at Nxera Pharma Ltd, and when
A new leader at Nxera Pharma Ltd brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Nxera Pharma Ltd raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Nxera Pharma Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nxera Pharma Ltd. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Nxera Pharma Ltd
Location
Tokyo, Tokyo, Japan
About
Nxera Pharma (formerly Sosei Heptares) is a technology powered biopharma company, in pursuit of new specialty medicines to improve the lives of patients with unmet needs in Japan and globally.
In addition to several products being commercialized in Japan, we are advancing an extensive pipeline of over 30 active programs from discovery through to late clinical stage internally and in partnership with leading pharma and biotech companies. This pipeline is focused on addressing major unmet needs in some of the fastest-growing areas of medicine across neurology, GI and immunology, metabolic disorders and rare diseases, and leverages the power of our unique and industry leading GPCR-targeted structure-based drug discovery “NxWave” platform to provide a sustainable source of best- or first-in-class candidates.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nxera Pharma Ltd changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
TokyoBiotechnologyPharmaceutical